SCHEMBL2004445

SCHEMBL2004445

CC(C)(C)C[C@H]1CN(Cc2ccc([N+](=O)[O-])cc2C(F)(F)F)CCN1C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNJ1 P48048 2/20 0.40
MGLL Q99685 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.37
KDM4E B2RXH2 4/20 0.36
ALDH1A1 P00352 3/20 0.36
ATM Q13315 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
TACR1 P25103 1/20 0.36
GAA P10253 1/20 0.36
AR P10275 1/20 0.36
NR1H2 P55055 1/20 0.36
LMNA P02545 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
TMPRSS2 O15393 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KIT P10721 1/20 0.35
HTR7 P34969 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2849487 0.86 MGLL (0.49) KCNJ1MGLLKDM4EALDH1A1ATM
SCHEMBL2849484 0.86 MGLL (0.49) KCNJ1MGLLKDM4EALDH1A1ATM
SCHEMBL377527 0.82 KDM4E (0.51) KCNJ1MGLLKDM4EALDH1A1LMNA
SCHEMBL377868 0.82 KDM4E (0.51) KCNJ1MGLLKDM4EALDH1A1LMNA
SCHEMBL2004443 0.79 ALDH1A1 (0.46) KCNJ1MGLLALDH1A1LMNAMEN1
SCHEMBL20912680 0.76 NR1H2 (0.44) KCNJ1MGLLKDM4EALDH1A1ATM
SCHEMBL20912684 0.76 NR1H2 (0.44) KCNJ1MGLLKDM4EALDH1A1ATM
SCHEMBL2004447 0.75 KCNJ1 (0.41) KCNJ1KDM4EALDH1A1ATMNPSR1
SCHEMBL1420633 0.75 NR1H2 (0.49) KCNJ1L3MBTL1KDM4EALDH1A1NR1H2
SCHEMBL588829 0.75 NR1H2 (0.62) KDM4EALDH1A1NR1H2LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7964597-B2 Piperazinyl-sulfonamide derivatives useful in the treatment of GPR38 receptor mediated diseases GLAXO GROUP LIMITED (GB) 2011-06-21 US disclosed